Alan Hodges

Alan Hodges

Auto-generated profile, based on publicly available information

Alan Hodges

Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Chemosphere
Verified
Journal Article
Closed access
AHAlan Hodges
Alan Hodges
ZFZachary Fica
Zachary Fica
JWJordan Wanlass
Jordan Wanlass
JVJessica VanDarlin
Jessica VanDarlin
RSRonald Sims
Ronald Sims

4 February 2021 in Cellular Immunology
Verified
Journal Article
Closed access
JZJilu Zhang
Jilu Zhang
AHAlan Hodges
Alan Hodges
SCShu-hsia Chen
Shu-hsia Chen
PPPING-YING PAN
PING-YING PAN

15 December 2023 in Cancer Research
Verified
Journal Article
Closed access
PDF file
SMSunny Mai
Sunny Mai
AHAlan Hodges
Alan Hodges
HCHui-Ming Chen
Hui-Ming Chen
JZJilu Zhang
Jilu Zhang
YWYi-Ling Wang
Yi-Ling Wang
PPPING-YING PAN
PING-YING PAN
Identifying novel cell surface receptors that regulate leukemia cell differentiation and can be targeted to inhibit cellular proliferation is crucial to improve current treatment modalities in acute myeloid leukemia (AML), especially for relapsed or chemotherapy-refractory leukemia. Leukocyte immunoglobulin-like receptor type B (LILRB) is an immunomodulatory receptor originally found to be expressed in myeloid cells. In this study, we found that LILRB receptors can be induced under inflammatory stimuli and chemotherapy treatment conditions. Blockade of LILRB3 inhibited leukemia cell proliferation and leukemia progression. In addition, treatment with LILRB3 blocking antibodies upregulated myeloid lineage differentiation transcription factors, including PU.1, C/EBP family, and IRF, whereas phosphorylation of proliferation regulators, for example, AKT, cyclin D1, and retinoblastoma protein, was decreased. Conversely, transcriptomic analysis showed LILRB3 activation by agonist antibodies may enhance leukemia survival through upregulation of cholesterol metabolism, which has been shown to promote leukemia cell survival. Moreover, LILRB3-targeted CAR T cells exhibited potent antitumor effects both in vitro and in vivo. Taken together, our results suggest that LILRB3 is a potentially potent target for multiple treatment modalities in AML. Significance: LILRB3 regulates differentiation and proliferation in acute myeloid leukemia and can be targeted with monoclonal antibodies and CAR T cells to suppress leukemia growth.

1 May 2014 in Journal of Agricultural and Applied Economics
Verified
Journal Article
Open access
PDF file
AHAlan W. Hodges
Alan W. Hodges
TSThomas J. Stevens
Thomas J. Stevens
AWAllen F. Wysocki
Allen F. Wysocki
A survey of 1599 randomly selected Florida households was conducted in 2012 to evaluate the consumer characteristics and economic impacts of local food purchases through retail stores, restaurants, and direct-to-consumer market channels. The total annual value of local food purchases averaged 10.47 billion in value-added, including regional multiplier effects for agricultural production and wholesale and retail distribution. These values are significantly higher than found in previous studies in other states.

29 July 2021 in Clinical Chemistry
Verified
Journal Article
Closed access
AHAlan Hodges
Alan Hodges
DBDebasish Boral
Debasish Boral